FDA approves IL-23 inhibitor risankizumab for treating plaque psoriasisApril 23, 2019PsoriasisPsoriatic Arthritis
TNF-alpha, adiponectin potential biomarkers for PsA, psoriasis differentiationApril 14, 2019PsoriasisPsoriatic Arthritis
Proinflammatory diet may not trigger adult psoriasis, PsA, or ADMarch 30, 2019PsoriasisPsoriatic Arthritis
Four biomarkers could distinguish psoriatic arthritis from osteoarthritisMarch 28, 2019Psoriatic Arthritis
Herpes zoster risk increased with some psoriasis, psoriatic arthritis treatmentsMarch 22, 2019PsoriasisPsoriatic Arthritis
FDA: Safety signal emerged with higher dose of tofacitinib in RA studyFebruary 26, 2019Psoriatic Arthritis
AAD, NPF release two joint guidelines on treatment, management of psoriasisFebruary 21, 2019PsoriasisPsoriatic Arthritis
Biologics curb coronary artery plaques in severe psoriasisFebruary 10, 2019PsoriasisPsoriatic Arthritis
Different disease features found with family history of psoriasis versus PsAFebruary 7, 2019Psoriatic ArthritisPsoriasis
